The Latest in Breast Cancer ICYMI

Treatment for hepatitis C reduces risk of Parkinson’s disease

June 6, 2019

Interview with Brenda L. Banwell, MD, on Pediatric-onset MS

June 6, 2019

2019 Update on menopause

June 4, 2019

Breast Cancer

ASCO clinical practice guideline update incorporates Oncotype DX

June 4, 2019

Breast Cancer

What to do when a patient presents with breast pain

June 4, 2019

Breast Cancer

Ribociclib/ET improves OS in premenopausal women with HR+/HER2- breast cancer

June 2, 2019

Breast Cancer

Ribociclib plus endocrine therapy boosts survival of HR+/HER2- breast cancer

June 1, 2019

Breast Cancer

FDA approves PI3K inhibitor alpelisib for breast cancer

May 24, 2019

Breast Cancer

Use of Oncotype DX to tailor breast cancer treatment likely to reduce costs

May 19, 2019

Breast Cancer

Diet linked to lower risk of death from breast cancer

May 16, 2019

Breast Cancer

ICYMI: Alpelisib/fulvestrant combo boosts PFS in advanced breast cancer

May 15, 2019

Breast Cancer

TVEC may improve response rates in nonmetastatic TNBC

May 15, 2019

Breast Cancer

BTK inhibitor reduces MS enhancing lesions

May 10, 2019

Interview with Stephen Krieger, MD, on the topographical model of multiple sclerosis

May 10, 2019

PROs in lung cancer and how to administer trastuzumab

May 10, 2019

Breast Cancer